BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xue R, Li R, Wang J, Tong W, Hao J. Horizons on the Therapy of Biliary Tract Cancers: A State-of-the-art Review. J Clin Transl Hepatol 2021;9:559-67. [PMID: 34447686 DOI: 10.14218/JCTH.2021.00007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liao R, Shi Y, Chuong MD, Cao J. Editorial: Gastrointestinal Tumor Heterogeneity and Related Anti-Cancer Strategies. Front Oncol 2022;12:873240. [DOI: 10.3389/fonc.2022.873240] [Reference Citation Analysis]
2 Wang Y, Yang X, Wang D, Yang X, Wang Y, Long J, Zhou J, Lu Z, Mao Y, Sang X, Guan M, Zhao H. Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma. Front Oncol 2022;12:785535. [DOI: 10.3389/fonc.2022.785535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]